Rare diseases
Investigational molecules
Locations
Back to Czechia7 clinical trials in Chrudim, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
CzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaStudy on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain
CzechiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CzechiaComparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Investigating the effectiveness of different chondroitin sulfate formulations in treating knee osteoarthritis, comparing bovine and marine sources to improve patient mobility and reduce pain.
Research focuses on evaluating treatment options for patients with moderate to severe knee pain.
Two major trials exploring treatments for heart conditions: one examining a novel combination therapy for heart failure, and another investigating stroke prevention in atrial fibrillation patients.
Innovative approaches to improving cardiovascular outcomes and patient care.
Groundbreaking research into new treatments for chronic non-specific low back pain, focusing on patients who haven't responded well to conventional non-opioid treatments.
Exploring innovative solutions for patients with treatment-resistant chronic pain conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
